2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease

Glenn N. Levine(American College of Cardiology), Duminda N. Wijeysundera(St. Michael's Hospital), Mark A. Hlatky(Cardiovascular Institute of the South), Eric Bates(Apple (Israel)), Christopher B. Granger(Clinical Research Institute), Roxana Mehran(Mount Sinai Hospital), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Biykem Bozkurt(Baylor College of Medicine), Marc S. Sabatine(Brigham and Women's Hospital), Richard A. Lange(Association of Chartered Certified Accountants), José A. Joglar, Ralph G. Brindis, L. Kristin Newby(Duke University), John S. Ikonomidis(University of North Carolina at Chapel Hill), Joaquin E. Cigarroa(Oregon Health & Science University), Patrick T. O’Gara(Brigham and Women's Hospital), Susan J. Pressler, Samuel S. Gidding(Genomic Health (United States)), Laura Mauri(Brigham and Women's Hospital), Sana M. Al‐Khatib(American Heart Association), John A. Bittl(Brigham and Women's Hospital), Lesley H. Curtis(Duke University), Kim K. Birtcher(University of Houston), Federico Gentile(Mayo Clinic), Peter K. Smith, Jonathan L. Halperin, Sidney C. Smith(American Heart Association), Lee A. Fleisher(Living Beyond Breast Cancer), Stephan D. Fihn(University of Washington), Debabrata Mukherjee(Texas Tech University)
Journal of Thoracic and Cardiovascular Surgery
October 15, 2016
Cited by 305


Related Papers